ATE206116T1 - 6-carboxamido-dihydropyran-derivate - Google Patents
6-carboxamido-dihydropyran-derivateInfo
- Publication number
- ATE206116T1 ATE206116T1 AT96911872T AT96911872T ATE206116T1 AT E206116 T1 ATE206116 T1 AT E206116T1 AT 96911872 T AT96911872 T AT 96911872T AT 96911872 T AT96911872 T AT 96911872T AT E206116 T1 ATE206116 T1 AT E206116T1
- Authority
- AT
- Austria
- Prior art keywords
- 6alkyl
- optionally substituted
- pct
- nr13r14
- substituted aryl
- Prior art date
Links
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 8
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 5
- 125000003107 substituted aryl group Chemical group 0.000 abstract 4
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 abstract 2
- 125000006649 (C2-C20) alkynyl group Chemical group 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000003358 C2-C20 alkenyl group Chemical group 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 101100294102 Caenorhabditis elegans nhr-2 gene Proteins 0.000 abstract 1
- 101100440695 Dictyostelium discoideum corB gene Proteins 0.000 abstract 1
- 150000008575 L-amino acids Chemical class 0.000 abstract 1
- 101150020251 NR13 gene Proteins 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- -1 amino, hydroxy Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229940042406 direct acting antivirals neuraminidase inhibitors Drugs 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 239000002911 sialidase inhibitor Substances 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Luminescent Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9510141.6A GB9510141D0 (en) | 1995-05-19 | 1995-05-19 | Chemical compounds |
| GBGB9525389.4A GB9525389D0 (en) | 1995-12-12 | 1995-12-12 | Chemical compounds |
| PCT/AU1996/000289 WO1996036628A1 (en) | 1995-05-19 | 1996-05-13 | 6-carboxamido dihydropyran derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE206116T1 true ATE206116T1 (de) | 2001-10-15 |
Family
ID=26307051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96911872T ATE206116T1 (de) | 1995-05-19 | 1996-05-13 | 6-carboxamido-dihydropyran-derivate |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5990156A (de) |
| EP (1) | EP0833825B1 (de) |
| JP (1) | JP4162712B2 (de) |
| KR (1) | KR19990014910A (de) |
| CN (1) | CN1184473A (de) |
| AT (1) | ATE206116T1 (de) |
| AU (1) | AU709127B2 (de) |
| CA (1) | CA2220754A1 (de) |
| CZ (1) | CZ366697A3 (de) |
| DE (1) | DE69615555T2 (de) |
| ES (1) | ES2164881T3 (de) |
| HU (1) | HUP9801766A3 (de) |
| NO (1) | NO975295D0 (de) |
| PL (1) | PL323471A1 (de) |
| WO (1) | WO1996036628A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5866601A (en) * | 1995-02-27 | 1999-02-02 | Gilead Sciences, Inc. | Carbocyclic compounds |
| CN100409844C (zh) | 1995-02-27 | 2008-08-13 | 吉里德科学公司 | 神经氨酸苷酶抑制剂 |
| US5763483A (en) * | 1995-12-29 | 1998-06-09 | Gilead Sciences, Inc. | Carbocyclic compounds |
| US5859284A (en) * | 1996-08-23 | 1999-01-12 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
| US6518438B2 (en) | 1996-08-23 | 2003-02-11 | Gilead Sciences, Inc. | Preparation of cyclohexene carboxylate derivatives |
| US5994377A (en) * | 1996-10-21 | 1999-11-30 | Gilead Sciences, Inc. | Piperidine compounds |
| US5886213A (en) * | 1997-08-22 | 1999-03-23 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
| US20040053999A1 (en) * | 1997-09-17 | 2004-03-18 | Bischofberger Norbert W. | Novel compounds and methods for synthesis and therapy |
| TW477783B (en) * | 1997-12-12 | 2002-03-01 | Gilead Sciences Inc | Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same |
| PT1040094E (pt) * | 1997-12-17 | 2009-06-03 | Biocryst Pharm Inc | Compostos de ciclopentano e de ciclopenteno substituídos úteis como inibidores da neuraminidase |
| US6518305B1 (en) | 1998-04-23 | 2003-02-11 | Abbott Laboratories | Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases |
| US6455571B1 (en) | 1998-04-23 | 2002-09-24 | Abbott Laboratories | Inhibitors of neuraminidases |
| US6593314B1 (en) | 1999-10-19 | 2003-07-15 | Abbott Laboratories | Neuraminidase inhibitors |
| US7045535B2 (en) * | 2001-03-08 | 2006-05-16 | Biocryst Pharmaceuticals, Inc. | Compounds useful for inhibiting paramyxovirus neuraminidase |
| WO2002092555A1 (en) * | 2001-05-11 | 2002-11-21 | Sankyo Company, Limited | Sialic acid derivatives |
| EP2427446B1 (de) * | 2009-05-04 | 2016-03-30 | National Research Council of Canada | Hemmer von sialidase oder sialidaseähnlichen enzymen |
| CN115991702B (zh) * | 2021-12-09 | 2024-02-02 | 珠海市藤栢医药有限公司 | 芳基c-葡萄糖苷衍生物、其制备方法及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK282950B6 (sk) * | 1990-04-24 | 2003-01-09 | Biota Scientific Management Pty Ltd | Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze |
| DE4131311A1 (de) * | 1991-09-20 | 1993-04-01 | Basf Ag | Dihydropyranderivate und diese enthaltende pflanzenschutzmittel |
| AU659501B2 (en) * | 1991-10-23 | 1995-05-18 | Biota Scientific Management Pty Ltd | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid |
| FR2687674B1 (fr) * | 1992-02-07 | 1995-05-19 | Roussel Uclaf | Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. |
-
1996
- 1996-05-13 AT AT96911872T patent/ATE206116T1/de not_active IP Right Cessation
- 1996-05-13 CN CN96194026A patent/CN1184473A/zh active Pending
- 1996-05-13 EP EP96911872A patent/EP0833825B1/de not_active Expired - Lifetime
- 1996-05-13 HU HU9801766A patent/HUP9801766A3/hu unknown
- 1996-05-13 WO PCT/AU1996/000289 patent/WO1996036628A1/en not_active Ceased
- 1996-05-13 PL PL96323471A patent/PL323471A1/xx unknown
- 1996-05-13 US US08/945,676 patent/US5990156A/en not_active Expired - Lifetime
- 1996-05-13 AU AU54932/96A patent/AU709127B2/en not_active Ceased
- 1996-05-13 CA CA002220754A patent/CA2220754A1/en not_active Abandoned
- 1996-05-13 ES ES96911872T patent/ES2164881T3/es not_active Expired - Lifetime
- 1996-05-13 JP JP53439196A patent/JP4162712B2/ja not_active Expired - Fee Related
- 1996-05-13 KR KR1019970708256A patent/KR19990014910A/ko not_active Withdrawn
- 1996-05-13 CZ CZ973666A patent/CZ366697A3/cs unknown
- 1996-05-13 DE DE69615555T patent/DE69615555T2/de not_active Expired - Fee Related
-
1997
- 1997-11-18 NO NO975295A patent/NO975295D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2220754A1 (en) | 1996-11-21 |
| CN1184473A (zh) | 1998-06-10 |
| JP4162712B2 (ja) | 2008-10-08 |
| AU709127B2 (en) | 1999-08-19 |
| JPH11505227A (ja) | 1999-05-18 |
| HUP9801766A2 (hu) | 2000-06-28 |
| EP0833825A4 (de) | 1998-10-07 |
| NO975295L (no) | 1997-11-18 |
| DE69615555T2 (de) | 2002-05-29 |
| NO975295D0 (no) | 1997-11-18 |
| DE69615555D1 (de) | 2001-10-31 |
| EP0833825B1 (de) | 2001-09-26 |
| ES2164881T3 (es) | 2002-03-01 |
| AU5493296A (en) | 1996-11-29 |
| EP0833825A1 (de) | 1998-04-08 |
| PL323471A1 (en) | 1998-03-30 |
| CZ366697A3 (cs) | 1998-04-15 |
| KR19990014910A (ko) | 1999-02-25 |
| US5990156A (en) | 1999-11-23 |
| HUP9801766A3 (en) | 2000-09-28 |
| WO1996036628A1 (en) | 1996-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69615555D1 (de) | 6-carboxamido-dihydropyran-derivate | |
| DK1163212T3 (da) | Amidderivater | |
| TR200001279T2 (tr) | Poli (ADP-riboz) polimeraz ("PARP") inhibitörleri, nevral ve kardiyovasküler doku hasarının tedavisi için yöntemler ve farmasötik bileşimler. | |
| TR200401432T4 (tr) | Admantan türevleri | |
| AR016001A1 (es) | Uso de polimeros de amina alifatica para la fabricacion de medicamentos para la reduccion de niveles de oxalato en un paciente | |
| GEP20043214B (en) | Complex of Ras-Farnesyltransferase Inhibitor and Sulfobutylether-7- Beta – Cyclodextrin or 2-Hydroxypropyl- Beta – Cyclodextrina and Pharmaceutical Compositions Containing the Same | |
| TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
| CY1107391T1 (el) | Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις | |
| DE59109082D1 (de) | Mono-N-substituierte 1,4,7,10-Tetraazacyclododecan-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel | |
| DE69613365D1 (de) | Ester der 5-aminolevulinsäure als mittel zur photosensibilisierung in der chemotherapie | |
| ATE279403T1 (de) | Dihydropyran-derivate als inhibitoren viraler neuramidase | |
| ATE442141T1 (de) | Verfahren zur behandlung von stoffwechselerkrankungen mit malonyl-coa- decarboxylase-hemmern | |
| GEP20032953B (en) | Antitumor Agents | |
| BG100930A (bg) | Фармацевтични състави и лекарствени средства за профилактика и лечение на ендотелиални нарушения | |
| DE60226446D1 (de) | Zusammensetzungen zur behandlung von neoplastischen krankheiten welche einen cyanoguanidine ikk inhibitor und ein zweites antineoplastisches arzneimittel enthalten | |
| ATE56946T1 (de) | Amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte. | |
| TR200001010T2 (tr) | Ürokinaz önleyicileri olan izokinolinler. | |
| DE69218816D1 (de) | N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt | |
| BR9807330A (pt) | Agentes inibidores do progresso de pterìgio e recorrência pós-operatória do mesmo | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| ATE245980T1 (de) | Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern | |
| CY1106472T1 (el) | Η χρηση των παραγωγων υδροξυπυριδονης στην επουλωση πληγων | |
| DE60006284D1 (de) | Arzneimittel zur behandlung konvulsivischer zustände | |
| ATE228359T1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten | |
| PT971714E (pt) | Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |